Neonatal hyperbilirubinemia is a leading cause of morbidity and mortality in developing countries with adverse consequences occur as neonatal mortality, cerebral palsy, isolated auditory impairment, and a diverse manifestation of subtle processing disorders because of bilirubin-induced neurologic dysfunction (BIND). In severe and rapidly increasing jaundice, the use of intensive phototherapy provides greater effectiveness and a faster decrement in bilirubin level.
This is a prospective study conducted on 40 neonates with severe hyperbilirubinemia admitted to NICU at Fayoum University Hospital, Faculty of Medicine, Fayoum University, Egypt in the period between April 2017 to October 2017. All newborns are subjected to intensive phototherapy (Bilisphere 360) and BIND score was assessed before and after administration of intensive phototherapy.
Our study showed that 55 % of babies were mild BIND, 40% were moderate and only 5% with severe BIND (before bilisphere). While 97.5% became normal BIND and 2.5% were moderate BIND (after bilisphere). KEYWORDS: BIND score, Hyperbilirubinemia, Intensive phototherapy.
INTRODUCTION:
Neonatal jaundice is defined as yellowish discoloration of skin, sclera of eyeball, and mucous membranes caused by deposition of bile in these tissues (1).
Globally, health care providers worldwide recognize that severe neonatal jaundice is a "silent" cause of significant neonatal morbidity and mortality. Untreated neonatal jaundice can lead to death in the neonatal period and to kernicterus, a major cause of neurologic disability (choreo-athetoid cerebral palsy, deafness and language difficulty) in children who survive this largely preventable neonatal problem (2).
BIND score is the score of onset, severity and progression of acute bilirubin encephalopathy in infants with hyperbilirubinemia (total serum bilirubin >95thpercentile for age in hours). The simplicity of the BIND scoring system, similar to the Apgar score, makes it an attractive tool for clinical diagnosis of ABE in resource limited locations that lack ready access to MRI and ABR (3).
Intensive phototherapy in neonatal hyperbilirubinemia rapidly decreases total serum bilirubin (TSB) below the threshold for exchange transfusion (4).
Bilisphere is a novel neonatal phototherapy device designed to provide blue light illumination to the whole of a baby's skin surface with high irradiance (5).
AIM OF THE WORK:
To evaluate the effectiveness of intensive phototherapy on bilirubin induced neurological dysfunction (BIND) score in neonates with severe hyperbilirubinemia (effectiveness on decreasing acute bilirubin encephalopathy), and minimizing the need for exchange transfuion.
PATIENTS AND METHODS:
This study was conducted on 40 neonates with severe hyperbilirubinemia admitted to NICU at Fayoum University Hospital, Egypt in the period between April 2017 to October 2017.The study was included neonates with severe hyperbilirubinemia necessitating intensive phototherapy.
Inclusion criteria:
Any newborn admitted with severe jaundice fulfilling the following data:
1. Gestational age ≥ 36 wks.
TSB ≥ 20mg/dl. Exclusion criteria:
 Congenital life threatening conditions e.g.; Birth defect and Congenital malformation.  Acquired life threatening conditions e.g.; shock, respiratory failure and post arrest.
Oral consents were obtained from parents or caregivers then all the neonates included in the study were subjected to the following:
A) Detailed History was taken with special regards to : Maternal history:  family history of neonatal jaundice.
Perinatal History:  Antenatal: gestational age.  Natal: mode of delivery.  Postnatal: age , sex and weight on admission.
B)Examination:
 Neurological examination was performed during the stay in our hospital every 8 hours.  Assessment of BIND score depends on :
 mental status.  muscle tone.  cry pattern of the neonates.  This score was done before and after intensive phototherapy. Score of 7 to 9: represent severe acute bilirubin encephalopathy; urgent interventions are recommended to possibly minimize further brain injury. Scoreof4 to 6: represent moderate acute bilirubin encephalopathy and is likely to be reversible with urgent bilirubin reduction. Scores of 1 to 3: represent mild acute bilirubin encephalopathy and are usually reversible with urgent bilirubin reduction strategies. C) Laboratory Investigation:
 Serum total bilirubin and direct bilirubin on admission and repeated after 8 hours.  Hemoglobin, reticulocytic count, Blood group ( ABO , RH grouping ) of the infant and mother.
D) Interventions:
All patients was subjected to intensive phototherapy (Bilisphere).
Statistical analysis
Data were collected, coded, revised and entered to the Statistical Package for Social Science (IBM SPSS) version 20. The data were presented as number and percentages for the qualitative data, mean, standard deviations and ranges for the quantitative data with parametric distribution and median with inter quartile range (IQR) for the quantitative data with non parametric distribution.
Paired t-test was used in the comparison between two groups with quantitative data for before and after and parametric distribution and Wilxon Rank test are used in the comparison between two groups with quantitative data for before and after and non parametric distribution.
The confidence interval was set to 95% and the margin of error accepted was set to 5%. So, the p-value was considered significant as the following: P > 0.05: Non significant (NS) P < 0.05: Significant (S) P < 0.01: Highly significant (HS) 
RESULTS

DISCUSSION:
In the current study we found that the mean of total serum bilirubin at admission was 25.49 with range from 20 to 38.1. This in agreement with the study conducted by AbdelLatif et al., in 2012 (6) that showed the mean TSB on admission for all the cases was 26.8 ± 6.2 mg/dL, also the study conducted by Iskander et al., in 2014 (7) , the mean total bilirubin at admission was 25.76 ± 4.39 mg/dL. Disagreement with our results the study conducted by Davutoglu et al., in 2010 (8), as the mean peak total bilirubin level was 28.1±6.4 mg/dL.
Results of this study showed that the rate of decline of TSB was 0.92 mg/dl/hr after 6-8hrs. Similar to our study De Carvalho et al., in 2011 (9), found that the rate of decline of TSB was 0.8 mg/dl/hr after 6 hours. Also  Al-Hafidh et al., in 2013 (10) found that the rate of decline was 0.81±0.38 mg/dl/hr. While Umran, in 2012 (11), reported that the reduction rate of total serum bilirubin was 1.3 mg/dl/hr. Also Abd-Ellatif et al., in 2012 found that the mean rate of TSB declined during stay in the bilisphere was 1.19 mg/dl/hr.
Bilirubin
induced neurological dysfunction (BIND) score was performed to all neonates in our study at admission and after 6-8 hr of intensive phototherapy. Neonates with BIND scores 1-3 represent cases with mild acute bilirubin encephalopathy, scores 4-6 represent cases with moderate acute bilirubin encephalopathy, while score 7-9 represent cases with severe acute bilirubin encephalopathy.
Our study showed that neonates with BIND score 1-3 (mild) in 55%, BIND score 4-6 (moderate) in 40%, while 5% of neonates have BIND score more than 6 (severe affection). After intensive phototherapy, neonates with mild and moderate BIND show normal BIND (97.5%). Neonates with severe BIND score (of 7-9) had persistent evidence of BE( 2.5%). Similar to our results et al., in 2011 (12) found that most of their neonates with neonatal hyperbilirubinemia had BIND score mild on admission in (60%), BIND score moderate in 32% neonates and only 8% had BIND score more than 6 (sever affection).
Gamaleldin
In the current study all neonates have intensive phototherapy and 27.5 % (11 newborns) of them needed single exchange transfusion. In contrast to this, Steiner et al., in 2007 (13) measured the efficacy of phototherapy in reduction of exchange transfusions in NICU and they found that only 2.8% (3 newborns) from 107 newborns required exchange transfusion. Also, Abd-Ellatif et al., in 2012 found that exchange blood transfusion was performed in 13 newborns out of 212 with extreme hyperbilirubinemia. This difference from our results could be explained due to their prolonged duration of intensive phototherapy (35.4±19.5) hours, compared to our duration (6-8 hours) and the greater number of babies than ours (40 newborns). Also Al-Hafidh et al., in 2013 found that exchange transfusion was not required in their study after intensive phototherapy. This difference can be explained by their lower initial TSB levels (18.85 ± 4.57mg/dl) compared than our levels.  BIND score should be used as a follow up measure for all cases with neonatal hyperbilirubinemia.
Recommendations
